PBE was created on 2005-06-23 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 269.9m in AUM and 32 holdings. PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.
Invesco Biotechnology & Genome ETF Información sobre dividendos
Invesco Biotechnology & Genome ETF tiene un dividendo anual de 0.00 por acción, con un rendimiento del 0.00%. El dividendo se paga trimestralmente y la última fecha ex-dividendo fue Dec 22, 2025.